为了解一类新的、以延缓肠道碳水化合物吸收而达到治疗糖尿病目的的药物-α-葡萄糖苷酶抑制剂-阿卡波糖（拜糖平），对非胰岛素依赖型糖尿病（下称NIDDM）的疗效，我们于1995年7月～1996年2月对30例NIDDM病人进行临床观察，结果如下。1．病例选择：30例NIDDM均符合WHO的糖尿病 In order to understand a new class of drugs, the α-glucosidase inhibitor-acarbose, that delays the intestinal absorption of carbohydrates to treat diabetes, non-insulin dependent diabetes mellitus (hereinafter referred to as NIDDM ), We in July 1995 ~ February 1996 on 30 cases of NIDDM clinical observation, the results are as follows. 1. Case selection: 30 cases of NIDDM are in line with WHO’s diabetes